Comparing total medical expenditure between patients receiving direct oral anticoagulants vs warfarin for the treatment of atrial fibrillation: evidence from VA-Medicare dual enrollees

BACKGROUND: Direct oral anticoagulants (DOACs) are an alternative to warfarin for treatment of atrial fibrillation (AF). Evidence demonstrating the efficacy and safety of DOACs has primarily been from clinical trial settings. The real-world effectiveness of DOACs in specific nontrial populations tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Edwin S, Done, Nicolae, Zhao, Molly, Woolley, Adam B, Prentice, Julia C, Mull, Hillary J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391145/
https://www.ncbi.nlm.nih.gov/pubmed/34337995
http://dx.doi.org/10.18553/jmcp.2021.27.8.1056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391145/
https://www.ncbi.nlm.nih.gov/pubmed/34337995
http://dx.doi.org/10.18553/jmcp.2021.27.8.1056

Ejemplares similares